secwatch / observer
8-K filed November 19, 2021, 6:59 PM ET ticker RGPX CIK 0001357878
leadership confidence high sentiment neutral materiality 0.65

Peptide Technologies names Gregory Pilant CEO/Chairman, Deborah Pilant Secretary/Treasurer

REGENEREX PHARMA, INC.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dennis Cox

Member of the Board of Directors
RGPX · REGENEREX PHARMA, INC.
Effective
2021-11-16
Filed
November 19, 2021, 6:59 PM ET
Effective November 16, 2021, Dennis Cox and Irene Getty tendered letters of resignation to the Company resigning from their positions as members of the Board of Directors.
Appointed

Deborah L. Pilant

Secretary/Treasurer
RGPX · REGENEREX PHARMA, INC.
Effective
2021-11-16
Filed
November 19, 2021, 6:59 PM ET
Effective November 16, 2021, Ms. Deborah L. Pilant has been appointed to serve as Secretary/Treasurer of the Company for the coming year.
Departed

Bruce Sellars

Chief Executive Officer
RGPX · REGENEREX PHARMA, INC.
Effective
2021-11-16
Successor
Gregory P. Pilant
Filed
November 19, 2021, 6:59 PM ET
Effective November 16, 2021, Bruce Sellars tendered his letter of resignation to the Company resigning from his position as Chief Executive Officer.
Appointed

Dr. Lee Ori

Chief Operating Officer
RGPX · REGENEREX PHARMA, INC.
Effective
2021-11-16
Filed
November 19, 2021, 6:59 PM ET
Effective November 16, 2021, Dr. Lee Ori has been appointed to serve as Chief Operating Officer of the Company for the coming year.
Appointed

Gregory P. Pilant

Chief Executive Officer and Chairman of the Board
RGPX · REGENEREX PHARMA, INC.
Effective
2021-11-16
Filed
November 19, 2021, 6:59 PM ET
Effective November 16, 2021, Mr. Gregory P. Pilant has been appointed to serve as Chief Executive Officer and Chairman of the Board for the Company for the coming year.
Departed

Irene Getty

Member of the Board of Directors
RGPX · REGENEREX PHARMA, INC.
Effective
2021-11-16
Filed
November 19, 2021, 6:59 PM ET
Effective November 16, 2021, Dennis Cox and Irene Getty tendered letters of resignation to the Company resigning from their positions as members of the Board of Directors.
Departed

Byron Striloff

President
RGPX · REGENEREX PHARMA, INC.
Effective
2021-11-16
Filed
November 19, 2021, 6:59 PM ET
Effective November 16, 2021, Byron Striloff tendered his letter of resignation to the Company resigning from his position as President of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dennis Cox resigned as Member of the Board of Directors at REGENEREX PHARMA, INC..

Action
resigned
Role
Member of the Board of Directors
Exact text from the filing
Effective November 16, 2021, Dennis Cox and Irene Getty tendered letters of resignation to the Company resigning from their positions as members of the Board of Directors.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Deborah L. Pilant was appointed as Secretary/Treasurer at REGENEREX PHARMA, INC..

Action
appointed
Role
Secretary/Treasurer
Exact text from the filing
Effective November 16, 2021, Ms. Deborah L. Pilant has been appointed to serve as Secretary/Treasurer of the Company for the coming year.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Bruce Sellars resigned as Chief Executive Officer at REGENEREX PHARMA, INC..

Action
resigned
Role
Chief Executive Officer
Exact text from the filing
Effective November 16, 2021, Bruce Sellars tendered his letter of resignation to the Company resigning from his position as Chief Executive Officer.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Lee Ori was appointed as Chief Operating Officer at REGENEREX PHARMA, INC..

Action
appointed
Role
Chief Operating Officer
Exact text from the filing
Effective November 16, 2021, Dr. Lee Ori has been appointed to serve as Chief Operating Officer of the Company for the coming year.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Gregory P. Pilant was appointed as Chief Executive Officer and Chairman of the Board at REGENEREX PHARMA, INC..

Action
appointed
Role
Chief Executive Officer and Chairman of the Board
Exact text from the filing
Effective November 16, 2021, Mr. Gregory P. Pilant has been appointed to serve as Chief Executive Officer and Chairman of the Board for the Company for the coming year.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Irene Getty resigned as Member of the Board of Directors at REGENEREX PHARMA, INC..

Action
resigned
Role
Member of the Board of Directors
Exact text from the filing
Effective November 16, 2021, Dennis Cox and Irene Getty tendered letters of resignation to the Company resigning from their positions as members of the Board of Directors.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Byron Striloff resigned as President at REGENEREX PHARMA, INC..

Action
resigned
Role
President
Exact text from the filing
Effective November 16, 2021, Byron Striloff tendered his letter of resignation to the Company resigning from his position as President of the Company.
View on SEC.gov

REGENEREX PHARMA, INC. filing history →

Source: SEC EDGAR
accession 0001472375-21-000139
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.